Back to Search
Start Over
The Evolving Continuum of Diagnosis in the Modern Age of Non-Small Cell Lung Cancer.
- Source :
-
Rhode Island Medical Journal . Sep2021, Vol. 104 Issue 7, p36-41. 6p. - Publication Year :
- 2021
-
Abstract
- Lung cancer remains the most common cause of cancer-related deaths in the United States. Traditional treatment of non-small cell lung cancer has included surgical resection for suitable candidates with early stage (I/II) disease and various chemoradiotherapeutic regimens used for advanced disease, for which prognosis has been poor. Since the early 2000s, there has been a revolution in the diagnosis and treatment of non-small cell lung cancer driven by improved diagnostic techniques and therapies targeted to druggable oncogenic drivers or manipulation of the immunologic milieu in the tumor microenvironment. With this has come a need for frequently updated comprehensive data regarding response to treatment and acquired resistance to targeted therapies. In this article, we aim to provide a concise review of the state-of-theart in lung cancer workup in 2021, with a focus on how molecular data now informs treatment decisions. With the burgeoning use of immunotherapeutic approaches, we will also discuss some of the complications seen, and briefly discuss their management. [ABSTRACT FROM AUTHOR]
- Subjects :
- *NON-small-cell lung carcinoma
*DIAGNOSIS
*PROGNOSIS
*LUNG cancer
Subjects
Details
- Language :
- English
- ISSN :
- 03637913
- Volume :
- 104
- Issue :
- 7
- Database :
- Academic Search Index
- Journal :
- Rhode Island Medical Journal
- Publication Type :
- Academic Journal
- Accession number :
- 152222379